News
3h
The National on MSNEmirati leads charge to reduce cost of one of world's most expensive cancer treatmentsAn Emirati doctor who found himself on the front lines against Covid-19 in the US during the pandemic is on a mission to ...
FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...
LEHIGH VALLEY, Pa. - American Cancer Society had some special guests at Saturday's telethon fundraiser. Two guests were ...
A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...
The Cell Shuttle was designed to help academic cell therapy developers by providing an integrated, automated solution.
Researchers have unlocked a powerful new way to fight solid tumors using smart immune cells that stay active longer and hit ...
Discover the long-term results of CAR T-cell therapy, with and without stem cell transplantation, for relapsed lymphoma ...
Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...
Driving Restrictions Beyond 1 Month After CAR-T Therapy Not Needed for All Patients, Researchers Say
Researchers proposed changing the recommendations for universal driving restrictions after CAR T-cell infusion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results